S&P Futures
3,827.25-0.75(-0.02%)Dow Futures
31,318.00-53.00(-0.17%)Nasdaq Futures
12,805.25-26.50(-0.21%)
Leidos Holdings, Inc. (LDOS)
88.00 -1.13 (-1.27%)
Pre-Market: 4:49AM EST
Chart Events
Performance Outlook
| Previous Close | 90.38 |
| Open | 90.00 |
| Bid | 0.00 x 800 |
| Ask | 91.27 x 800 |
| Day's Range | 87.97 - 90.25 |
| 52 Week Range | 68.00 - 113.75 |
| Volume | 1,679,502 |
| Avg. Volume | 807,113 |
| Market Cap | 12.647B |
| Beta (5Y Monthly) | 1.00 |
| PE Ratio (TTM) | 20.44 |
| EPS (TTM) | 4.36 |
| Earnings Date | May 03, 2021 - May 07, 2021 |
| Forward Dividend & Yield | 1.36 (1.50%) |
| Ex-Dividend Date | Mar 12, 2021 |
| 1y Target Est | 115.80 |
Fair Value
Related Research
- Newsfile
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Leidos Holdings, Inc. (LDOS) for Possible Securities Fraud, Encourages LDOS Investors to Contact Its Attorneys Now, Analyst Calls Asset a "Total Black Box"
San Francisco, California--(Newsfile Corp. - February 25, 2021) - Hagens Berman urges Leidos Holdings, Inc. (NYSE: LDOS) investors to submit their losses now. The firm is investigating a potential securities fraud.Visit: www.hbsslaw.com/investor-fraud/LDOSContact An Attorney Now: LDOS@hbsslaw.com844-916-0895Leidos Holdings, Inc. (LDOS) Investigation:The firm is investigating whether Leidos misrepresented and concealed problems with its Security Detection and Automation (SD&A) business.In May 2020, Leidos acquired L3Harris' SD&A business for $1 billion, claiming the deal would help ...
- EH Breaking Alert: Rosen, A Top Ranked Law Firm, Encourages EHang Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - EHNewsfile
- EBIX SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Ebix (EBIX) Investors to Contact Firm Now, Securities Fraud Case FiledNewsfile
- GlobeNewswire
Leidos Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their lossesLOS ANGELES, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Leidos Holdings, Inc. ("Leidos" or the "Company") (NYSE: LDOS) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses. On February 16, 2021, it was reported by Spruce Point Capital Management that “Leidos’ $1.0 billion levered acquisition of L3Harris’ Security Detection and Automation business (SD&A) is experiencing significant problems, including product defects, that increase the likelihood of a material adverse effect.” This report continued to allege that Leidos misstated its revenue, citing, for example, a $6 million variance between the third quarter 2020 investor presentation and a Form 10-Q, which “raises the possibility that Leidos has booked fake revenue, or is keeping two sets of books.” On February 16, 2021, Leidos stock dropped $3.41 per share, or roughly 3%, to close at $105.22 on following this news. Please visit our website to review more information and submit your transaction information. The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes. Lesley F. Portnoy, Esq.Admitted CA and NY Barlesley@portnoylaw.com310-692-8883www.portnoylaw.com Attorney Advertising
- INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Infinity Q Capital Management LLC and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire
- INFINITY Q NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Infinity Q Diversified Alpha Fund Investors to Inquire About Class Action Investigation – IQDNX, IQDAXGlobeNewswire
- PR Newswire
DTRA Awards Leidos Project to Conduct Clinical Trials for COVID-19 Therapeutics
Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, was recently awarded a new project agreement by the Defense Threat Reduction Agency (DTRA) to conduct clinical studies of therapeutics for treating COVID-19. The cost-plus-fixed-fee agreement was awarded through the Medical CBRN Defense Consortium. It holds a base value of $22 million and a base period of performance of 24 months.
